Blacks and Latinos are disproportionately affected by COVID-19, according to new data from scientists at 23andMe, illustrating the racial disparities in the impact of the virus.

23andMe added a new Genetic Health Risk report on APOL1-related chronic kidney disease that has particular relevance for customers with African ancestry.

A drug to fight cancer will be the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration as the two companies announced that the new therapy will begin clinical trials.

We sit down for a chat with L. Okey Onyejekwe Jr., 23andMe’s new vice president of Consumer Clinical Operations & Medical Affairs.

Published today in the American Journal of Human Genetics, a paper by 23andMe scientists using genetic data offers one of the most comprehensive investigations of the transatlantic slave trade ever done.

Ann, a genetics professor, used 23andMe to find her mother’s sister. But 23andMe also offered a gift of knowledge with insight into her ancestry and health.

Using data from the UK Biobank and 23andMe, researchers found new genetic associations for allergies, asthma, and eczema by studying the age of onset.

23andMe joined with seven other companies as a Founding Partner to assist in the launch of iHeartMedia’s BIN: Black Information Network.

Pride month is a time to celebrate the love that’s in all our DNA, regardless of someone’s sexual orientation or gender identity. But even though we are all 99.5 percent genetically identical, we still aren’t treated 100 percent equally. 23andme is doing its part to make sure employees and customers are treated equally no matter their sexual orientation or gender identity.

23andMe updated its G6PD Deficiency Genetic Health Risk Report* that now includes the two most common variants linked to G6PD  deficiency, a condition that can lead to episodes of anemia. The update makes this report more comprehensive, and relevant for more people.